Arena Investors’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Arena Investors’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$21.3K	Hold	85,000	–	–	0.17%	12
2024 Q1	$56.4K	Hold	85,000	–	–	0.85%	7
2023 Q4	$118K	Hold	85,000	–	–	0.62%	9
2023 Q3	$131K	Hold	85,000	–	–	0.15%	28
2023 Q2	$149K	Hold	85,000	–	–	0.13%	43
2023 Q1	$83.3K	Hold	85,000	–	–	0.06%	43
2022 Q4	$84.2K	Hold	85,000	–	–	0.08%	54
2022 Q3	$16.2K	Hold	85,000	–	–	0.01%	124
2022 Q2	$15K	Hold	85,000	–	–	0.01%	137
2022 Q1	$21K	Hold	85,000	–	–	0.01%	98
2021 Q4	$29.8K	Buy	+85,000	New	+$33.8K	0.03%	27

Other funds holding RVPHW

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arena Investors's RVPHW Position: Q2 2024 in Review

Arena Investors held its Reviva Pharmaceuticals Warrants (RVPHW) position steady in Q2 2024 at 85,000 shares worth $21.3K. The position accounts for 0.17% of the portfolio, ranked #12.

Arena Investors first reported a position in RVPHW in Q4 2021 and has held it in 11 quarters since. The position peaked at $149K in Q2 2023. 4 funds tracked by Wall St. Rank hold RVPHW as of Q2 2024.

Arena Investors held 85,000 shares of Reviva Pharmaceuticals Warrants worth $21.3K as of Q2 2024.
Arena Investors left its Reviva Pharmaceuticals Warrants share count unchanged in Q2 2024.
Reviva Pharmaceuticals Warrants made up 0.17% of Arena Investors's portfolio in Q2 2024, its #12 holding.
Arena Investors first reported a position in Reviva Pharmaceuticals Warrants in Q4 2021 and has held it in 11 quarters since.
Arena Investors's Reviva Pharmaceuticals Warrants position peaked at $149K in Q2 2023.
4 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q2 2024.

Based on Arena Investors's 13F filing for Q2 2024, filed 14 Aug 2024.